beyfortus solución inyectable 50 mg/0,5 ml (nirsevimab)
sanofi pasteur s.a. - nirsevimab - sin formulas
beyfortus solución inyectable 100 mg/1 ml (nirsevimab)
sanofi pasteur s.a. - nirsevimab - sin formulas
beyfortus
astrazeneca ab - nirsevimab - los sueros inmunes e inmunoglobulinas, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - los sueros inmunes e inmunoglobulinas, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. ver secciones 4. 4 y 5.
irbevitae 300mg comprimido recubierto
galenicum vitae peru s.a.c. - droguerÍa - irbesartan; - comprimido recubierto - por comprimido - - irbesartán
irbevitae 150mg comprimido recubierto
galenicum vitae peru s.a.c. - droguerÍa - irbesartan; - comprimido recubierto - por comprimido - - irbesartán
irbevitae plus 300 mg + 25 mg comprimido recubierto
galenicum health peru s.a.c. - comprimido recubierto - por comprimido - irbesartan y diuréticos
ronapreve 120 mg/ml + 120 mg/ml solucion inyectable y para perfusion
roche farma (peru) s.a. - droguerÍa - casirivimab + imdevimab - solucion inyectable y para perfusion - 120mg/ml + 120mg/ml - por vial 11.10 ml - - casirivimab y imdevimab
ronapreve 300 mg + 300 mg solucion inyectable y para perfusion
roche farma (peru) s.a. - droguerÍa - casirivimab + imdevimab - solucion inyectable y para perfusion - 300mg +300mg - por vial 300.00 mg - - casirivimab y imdevimab
dolo-nervimax solución inyectable 75 mg/3ml
j.r. drogueria - solución inyectable - 75 mg/3ml